Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Tl32711
1. 1260251-31-7
2. Birinapant (tl32711)
3. Tl-32711
4. Tl32711
5. Tl 32711
6. (2s)-n-[(2s)-1-[(2r,4s)-2-[[6-fluoro-2-[6-fluoro-3-[[(2r,4s)-4-hydroxy-1-[(2s)-2-[[(2s)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]methyl]-1h-indol-2-yl]-1h-indol-3-yl]methyl]-4-hydroxypyrrolidin-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide
7. 6o4z07b57r
8. Birinapant [usan]
9. (2s,2's)-n,n'-((2s,2's)-((3s,3's,5r,5'r)-5,5'-((6,6'-difluoro-1h,1'h-[2,2'-biindole]-3,3'-diyl)bis(methylene))bis(3-hydroxypyrrolidine-5,1-diyl))bis(1-oxobutane-2,1-diyl))bis(2-(methylamino)propanamide)
10. (2s,2's)-n,n'-[(6,6'-difluoro-1h,1'h-2,2'-biindole-3,3'-diyl)bis{methanediyl[(2r,4s)-4-hydroxypyrrolidine-2,1-diyl][(2s)-1-oxobutane-1,2-diyl]}]bis[2-(methylamino)propanamide]
11. Birinapant [usan:inn]
12. Unii-6o4z07b57r
13. Birinapant Di-hcl
14. Propanamide, N,n'-((6,6'-difluoro(2,2'-bi-1h-indole)-3,3'-diyl)bis(methylene((2r,4s)-4-hydroxy-2,1-pyrrolidinediyl)((1s)-1-ethyl-2-oxo-2,1-ethanediyl)))bis(2-(methylamino)-, (2s,2's)-
15. Propanamide, N,n'-[(6,6'-difluoro[2,2'-bi-1h-indole]-3,3'-diyl)bis[methylene[(2r,4s)-4-hydroxy-2,1-pyrrolidinediyl][(1s)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-, (2s,2's)-
16. Birinapant [inn]
17. Birinapant (usan/inn)
18. Birinapant [who-dd]
19. Mls006011237
20. Gtpl7432
21. Tl32711 2hcl
22. Chembl3039522
23. Schembl10049847
24. Dtxsid30155057
25. Ex-a258
26. Tl-32711 2hcl
27. Chebi:177705
28. Bdbm50071920
29. Mfcd25976869
30. Nsc767128
31. Nsc816007
32. S7015
33. Zinc96941868
34. Akos030526366
35. Ccg-270498
36. Cs-1719
37. Db11782
38. Nsc-767128
39. Nsc-816007
40. Ac-32868
41. As-17035
42. Hy-16591
43. Smr004702997
44. Sw220103-1
45. D10417
46. A852939
47. Q27075298
48. (2s)-n-[(2s)-1-[(2r,4s)-2-[[6-luoro-2-[6-luoro-3-[[(2r,4s)-4-hydroxy-1-[(2s)-2-[[(2s)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]methyl]-1h-indol-2-yl]-1h-indol-3-yl]methyl]-4-hydroxypyrrolidin-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide
49. (2s,2's)-n,n'-((2s,2's)-1,1'-((3s,3's,5r,5'r)-5,5'-(6,6'-difluoro-1h,1'h-2,2'-biindole-3,3'-diyl)bis(methylene)bis(3-hydroxypyrrolidine-5,1-diyl))bis(1-oxobutane-2,1-diyl))bis(2-(methylamino)propanamide)
50. (2s,2's)-n,n'-[(6,6'-difluoro-1h,1'h-2,2'-biindole-3,3'-diyl)bis{methanediyl[(2r,4s)-4-hydroxypyrrolidine-2,1-diyl][(2s)-1-oxobutane-1,2-diyl]}]bis[2-(methylamino)propanamide] (non-preferred Name)
51. Gt6
52. N,n'-((6,6'-difluoro(1h,1'h-2,2'-biindole)- 3,3'-diyl)bis(methylene((2r,4s)-4-hydroxypyrrolidine-2,1-diyl)((2s)-1- Oxobutane-1,2-diyl) Bis((2s)-2-(methylamino)propanamide)
Molecular Weight | 806.9 g/mol |
---|---|
Molecular Formula | C42H56F2N8O6 |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 15 |
Exact Mass | 806.42908786 g/mol |
Monoisotopic Mass | 806.42908786 g/mol |
Topological Polar Surface Area | 195 Ų |
Heavy Atom Count | 58 |
Formal Charge | 0 |
Complexity | 1350 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
51
PharmaCompass offers a list of Birinapant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Birinapant manufacturer or Birinapant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Birinapant manufacturer or Birinapant supplier.
PharmaCompass also assists you with knowing the Birinapant API Price utilized in the formulation of products. Birinapant API Price is not always fixed or binding as the Birinapant Price is obtained through a variety of data sources. The Birinapant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Birinapant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Birinapant, including repackagers and relabelers. The FDA regulates Birinapant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Birinapant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Birinapant supplier is an individual or a company that provides Birinapant active pharmaceutical ingredient (API) or Birinapant finished formulations upon request. The Birinapant suppliers may include Birinapant API manufacturers, exporters, distributors and traders.
Birinapant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Birinapant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Birinapant GMP manufacturer or Birinapant GMP API supplier for your needs.
A Birinapant CoA (Certificate of Analysis) is a formal document that attests to Birinapant's compliance with Birinapant specifications and serves as a tool for batch-level quality control.
Birinapant CoA mostly includes findings from lab analyses of a specific batch. For each Birinapant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Birinapant may be tested according to a variety of international standards, such as European Pharmacopoeia (Birinapant EP), Birinapant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Birinapant USP).